Emmaus Life Sciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

DERIVATIVE LIABILITIES (Details Textual)

DERIVATIVE LIABILITIES (Details Textual) (USD $)	3 Months Ended	6 Months Ended
DERIVATIVE LIABILITIES (Details Textual) (USD $)	Mar. 31, 2015	Mar. 31, 2015	Sep. 30, 2014	Sep. 22, 2014
Derivatives, Fair Value [Line Items]
Derivative Liability	$ 85,800us-gaap_DerivativeLiabilities	$ 85,800us-gaap_DerivativeLiabilities
Derivative, Gain on Derivative		99,300us-gaap_DerivativeGainOnDerivative
Derivative Financial Instruments, Liabilities [Member] \| September 2014 Notes [Member]
Derivatives, Fair Value [Line Items]
Proceeds from Convertible Debt		2,070,000
Derivative Liability	85,800	85,800	153,100	179,200
Derivative, Gain on Derivative	$ 139,200	$ 99,300
Derivative Financial Instruments, Liabilities [Member] \| Maximum [Member] \| September 2014 Notes [Member]
Derivatives, Fair Value [Line Items]
Debt Instrument, Convertible, Conversion Price	$ 0.25	$ 0.25
Derivative Financial Instruments, Liabilities [Member] \| Minimum [Member] \| September 2014 Notes [Member]
Derivatives, Fair Value [Line Items]
Debt Instrument, Convertible, Conversion Price	$ 0.10	$ 0.10

- Definition

Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.

+ References + Details